Where did Stefan Hart go to school?

Stefan Hart studied at Max-Planck-Institute of Biochemistry (PhD, Biochemistry).

Stefan Hart

Investor

Senior Director, Scientific Innovation, Oncology at Johnson & Johnson Innovation – JJDC

Spain

Find your path to Stefan

222 people in our graph share verified history with Stefan — schools, employers, funds. One of them is your warm intro.

KobeunlockedStefan: together at Johnson & Johnson (2014–2020)

×7Stefan: together at Johnson & Johnson

×2Stefan: together at Institute of Medical Biology

Stefan: together at Johnson & Johnson Innovation – JJDC

About

Stefan Hart is Vice President, Oncology Scientific Innovation at Johnson & Johnson Innovative Medicine, with 14 years of experience across pre-clinical and clinical research. He has served as project leader in oncology discovery and early development, including work on VS-5584 and Pacritinib, and has additional experience in ophthalmology and inflammation. His responsibilities have included leading cellular assay and biomarker teams, conducting scientific scouting and technical due diligence, defining research strategy, and managing project budgets and milestones across academic, biotech, and pharmaceutical settings.

Experience

Johnson & JohnsonVice President, Oncology Scientific Innovationcurrent2024 — presentSingapore, Singapore
Johnson & JohnsonSenior Director, Scientific Innovation Oncology2017 — 2024Singapore
Johnson & JohnsonSenior Director, New Ventures Singapore/SEA/India at J&J Innovation Center Asia Pacific2017Singapore
Johnson & JohnsonDirector, New Ventures Singapore/SEA/India2014 — 2017
Roche PharmaceuticalsManager Pre-clinical Research Academic Alliances2011 — 2014Singapore
S*BIO Pte LtdSenior Scientist, Team Leader2008 — 2012Singapore
Institute of Medical BiologySenior Research Fellow2004 — 2007
Max Planck Institute for BiochemistryPHd Student2000 — 2004
Roche BioscienceInternship1998 — 1999Palo Alto, CA

Skills & more

Drug Discovery26Biomarkers14Oncology15Clinical Development10Translational Research4Cell8Biotechnology17Molecular Biology17In Vivo3Clinical Research2Biochemistry6Lifesciences2

+4 more

TennisDrug DevelopmentTeam LeadershipProjectLeader

Languages English · German

From Stefan's professional profile.

Colleagues at Johnson & Johnson Innovation – JJDC

Ahryon Cho

Regional Head, JLABS Korea at Johnson & Johnson Innovation – JJDC

Amir Blatt

Founding Partner and CIO at Almeda Ventures

Anurag Mehta

Principal at Johnson & Johnson Innovation – JJDC

Asha Nayak

Investor at Johnson & Johnson Innovation – JJDC

Asish K. Xavier

Vice President, Venture Investments at JJDC

Aurelie Gaudin

Associate Director, Global Campaigns & Audience Engagement at Johnson & Johnson Innovation – JJDC

Chelsea Hewitt

Senior Director, Regional Engagement & Incubation, San Diego, External Scientific Innovation at Johnson & Johnson Innovation – JJDC

Chris Haskell

Head of JLABS @ San Francisco Bay Area at Johnson & Johnson Innovation – JJDC

Frequently asked questions

Who is Stefan Hart?: Stefan Hart is Vice President, Oncology Scientific Innovation at Johnson & Johnson Innovative Medicine, with 14 years of experience across pre-clinical and clinical research. He has served as project leader in oncology discovery and early development, including work on VS-5584 and Pacritinib, and has additional experience in ophthalmology and inflammation. His responsibilities have included leading cellular assay and biomarker teams, conducting scientific scouting and technical due diligence, defining research strategy, and managing project budgets and milestones across academic, biotech, and pharmaceutical settings.
Where does Stefan Hart work?: Stefan Hart is Senior Director, Scientific Innovation, Oncology at Johnson & Johnson Innovation – JJDC.
Where did Stefan Hart go to school?: Stefan Hart studied at Max-Planck-Institute of Biochemistry (PhD, Biochemistry).

Shared employers

Also worked at Johnson & Johnson363

Teresa ChanChief Financial Officer at Felicis Ventures Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird Ventures MickelFinance & Risk Management at Hummingbird Ventures Hal PazInvestor at Khosla Ventures Niall O'DonnellManaging Director at RiverVest Venture Partners

+ 357 more

Also worked at Roche Pharmaceuticals229

Joe HorsmanInvestor at Madrona Venture Group Marco PrunottoInvestor at Medicxi Mike FitzgeraldInvestor at High Alpha Uri LopatinInvestor at Khosla Ventures Jan-Olivier FillolsSenior Managing Director at Marlin Equity Partners Cyndi ReseburgInvestor at Initialized Capital

+ 223 more

Also worked at Institute of Medical Biology54

Kelven LamInvestment Director - Water at Emerald Technology Ventures Ag Anqi ChenInvestment Manager at Qualgro Dr Jeremy LimHealthcare Strategist at Verge HealthTech Fund Akanksha JagwaniInvestor at FEBE Ventures Dr. Sidney YeeVenture Partner at iGlobe Partners Fong Ming KohPrincipal at LYFE Capital

+ 48 more

Also worked at Max Planck Institute for Biochemistry6

Mathias FalcenbergVenture Partner at V-Bio Ventures Claudio NessiManaging Director at Omega Funds Philipp BräuerVice President at EQT Life Sciences Alexandra GrigoreChief Strategy Officer and Co-founder at Simprints Rositsa JordanovaChief Executive Officer & Co-Founder at Protyon Robert EnglmeierStructural Biologist, Co-Founder & CEO at Cryocloud